Cargando…
Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury
Acute lung injury (ALI) is a life-threatening acute inflammatory disease with limited options available for therapy. Myeloid differentiation protein 2, a co-receptor of TLR4, is absolutely required for TLR4 sense LPS, and represents an attractive target for treating severe inflammatory diseases. In...
Autores principales: | Zhang, Yali, Wu, Jianzhang, Ying, Shilong, Chen, Gaozhi, Wu, Beibei, Xu, Tingting, Liu, Zhiguo, Liu, Xing, Huang, Lehao, Shan, Xiaoou, Dai, Yuanrong, Liang, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846832/ https://www.ncbi.nlm.nih.gov/pubmed/27118147 http://dx.doi.org/10.1038/srep25130 |
Ejemplares similares
-
Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS‐induced acute lung injury
por: Zhang, Yali, et al.
Publicado: (2016) -
Inhibition of epidermal growth factor receptor attenuates LPS-induced inflammation and acute lung injury in rats
por: Shan, Xiaoou, et al.
Publicado: (2017) -
A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo
por: Ge, Xiangting, et al.
Publicado: (2016) -
Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease
por: Zhang, Yali, et al.
Publicado: (2017) -
Synthesis and Evaluation of a Series of Novel Asymmetrical Curcumin Analogs for the Treatment of Inflammation
por: Zhang, Yali, et al.
Publicado: (2014)